Home > Healthcare & Medical Devices > Clinical Nutrition Market

Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI1324
  • Base Year: 2020
  • Report Format: PDF

Industry Trends

Clinical Nutrition Market size was valued at over USD 45.8 billion in 2020 and is estimated to grow at a CAGR of more than 8% from 2021 to 2027. Growing incidence of chronic and metabolic disorders is stimulating the market growth. Surging geriatric population base and increasing number of people affected with malnutrition are anticipated to increase the adoption of clinical nutrition products in the market. In addition to this, shifting consumer trends related to food consumption and growing demand for nutritional products, are further expected to augment the market expansion.

Clinical Nutrition Market Overview

Get more details on this report - Request Free Sample PDF

Clinical nutrition deals with the diagnosis, management and prevention of metabolic and nutritional conditions associated with chronic or acute disorders resulting due to dearth of energy and nutrients. Clinical nutrition products are significant in promoting patient health and facilitate improvement in the metabolic system by offering essential nutrients such as vitamins, minerals and other supplements. Clinical nutrition assists in better recovery in several chronic conditions such as malnutrition, obesity, cancer, and cardiovascular diseases among others. 

However, lack of awareness regarding adequate use of clinical nutrition, especially in developing countries may hinder the market progression. Dearth of knowledge related to clinical nutrition results in inadequate dietary choices causing poor diet quality, thereby increasing the risk of chronic ailments. Additionally, lack of awareness boosts the prevalence of malnutrition, thereby increasing mortality and morbidities among consumers. Malnutrition is responsible for around 300,000 deaths annually and indirectly associated with over half of the deaths in young children.

Moreover, clinical nutrition products are required to comply with the labelling requirements provided by the U.S. FDA. These requirements include guidelines issued under the FD&C Act. Along with this, several others mandate such as current good manufacturing practice (CGMP) (21 CFR part 110), registration of food facilities (21 CFR part 1 subpart H), emergency permit control (21 CFR part 108) and others are also edict. Furthermore, the Food Allergen Labelling and Consumer Protection Act of 2004 (FALCPA) apply to clinical nutrition products.

The COVID-19 pandemic has emerged as an unprecedented health concern that has rendered significant impact on the clinical nutrition market. The coronavirus outbreak has affected over millions of people across the globe causing significant mortalities. In order to curb the further transmission of SARS-CoV-2 virus, nationwide lockdowns were imposed, and emergencies had been declared in majority of the countries. The shutdown of major sectors of the economy distorted the supply chain and restricted the movement of raw materials that may limit the industry revenue to a certain extent.

However, medical nutrition is vital in fast recovery and health management in COVID-19 patients. Clinical outcome and recovery are low in patients that are at risk for obesity and malnutrition. As a result, clinical nutritional care is advised for COVID-19 patients. For instance, the European Society for Clinical Nutrition and Metabolism (ESPEN) published clinical guidelines associated with nutritional management in severely infected COVID-19 patients. The SARS-CoV-2 virus is often characterized by prolonged immobilization that reduces certain muscle functions, causes lack of appetite, diarrhoea, sarcopenia that augments the risk of malnutrition. As a response to this scenario, the hospitals have increased the availability of units for critical patients that require disease specific nutrition. This development is expected to increase the demand and adoption of clinical nutrition products.

Growing prevalence of metabolic disorders and chronic diseases is anticipated to fuel the clinical nutrition market value

Rising prevalence of metabolic disorders drives the demand for clinical nutrition. Drastic increase in lifestyle-associated ailments such as obesity, malnutrition, type-2 diabetes, and cardiovascular disease among others lead to prolonged hospitalization, disability and mortality. Cardiovascular diseases (CVD) are responsible for more than 4 million deaths on an annual basis that represents 49% of the mortalities in Europe. According to the American Diabetes Association (ADA), metabolic disorders such as abdominal obesity, hypertriglyceridemia, high blood pressure are growing exponentially. Similarly, the Centers for Disease Control and Prevention (CDC) reported that in 2017, around 30.2 million adults aged over 18 years & older in the U.S. had type 2 diabetes. The incidence of diabetes is further forecasted to increase substantially with growing age accounting for 25.2% of the elderly population group in the U.S. (65 years or older), thereby fostering the industry growth.

The management of these chronic diseases is generally multidimensional that comprises several aspects including medical nutrition. Medical nutrition plays an anchoring role in chronic disease management as diet is one of the crucial factors in treatment. The rise in metabolic diseases and related mortality offers immense potential for business growth and opportunity for the industry players to establish and penetrate the untapped market.

Increasing incidence of preterm births and awareness campaigns will stimulate the product acceptance

The infant nutrition segment dominated more than 54.7% of the clinical nutrition market share in 2020 led by the growing preterm births across the globe and several campaigns started by public organizations and governments for promoting the use of medical nutrition products to improve the nutritional intake of new-borns. According to the World Health Organization (WHO), approximately 15 million babies are born premature annually and 1 million children among these die every year due to several complications of preterm birth. These babies have poor cognitive abilities, visual & hearing problems and malnutrition among others.

Prematurity is one of the leading factors responsible for high mortality aged under 5 years. The increasing frequency and incidence of preterm babies are slated to accelerate the demand for medical nutrition to meet energy requirements and other clinical nutritional needs. Majority of preterm births are reported in South Asia and Africa, especially in developing countries such as India, Nigeria, Indonesia, Philippines and others. These factors provide the market expansion opportunities for the major players to expand in developing economies, further influencing the segment growth.

High prevalence of malnutrition causing significant mortality and co-morbidities in children is set to promote the segment expansion

The pediatric segment in the clinical nutrition market accounted for 58.7% of revenue share in 2020 owing to high prevalence of malnutrition and related conditions across the world. Malnutrition is a leading factor causing high mortalities and morbidities, especially in the under-developed and developing economies. Around 60 million children are affected with moderate malnutrition and 13 million with severe acute malnutrition, globally. According to the World Health Organization (WHO), nearly 5.4 million children succumb to malnutrition annually, with 2.7 million deaths reported in Sub-Saharan African region.

Child malnutrition is accompanied by other complications such as slow physical growth, lower intellectual quotient (IQ), poor social skills, and high-risk regarding susceptibility to contracting diseases. Malnutrition also causes problems such as iron deficiency anaemia, which is another cause resulting in higher infant mortality and morbidity worldwide. Hence, the usage of medical nutrition products may help in reducing these problems as a nutritionally optimal and balanced diet is vital to prevent these psychological and physical adverse effects.

High prevalence of cancer is projected to boost the clinical nutrition market revenue

Clinical Nutrition Market Size

Get more details on this report - Request Free Sample PDF


The cancer segment exceeded USD 7.1 billion in 2020 on account of the rising prevalence of cancer and growing awareness regarding significance of clinical nutrition in cancer treatment. Cancer is amongst the leading factors causing high mortalities globally. According to the National Cancer Institute estimates, in 2020, around 1.8 million new cases of cancer are slated to be diagnosed in the U.S. Further, out of these diagnosed cases, over 600,000 people are set to die owing to cancer.

Cancer is accompanied by several conditions including nutritional and metabolic alterations such as cancer cachexia, malnutrition and sarcopenia that hamper the recovery process and reduce survival chances of cancer patients. Malnutrition promotes anorexia and accelerates weight loss in cancer patients and is highly prevalent affecting around 15 to 40% of the patients. Estimates highlight that 40 to 80% of people affected with cancer are malnourished during the onset of the disease. Increasing prevalence and burden of cancer is expected to augment the acceptance and demand for clinical nutrition.

Rising consumer preference for online channel enhances the market growth

The online channel segment in the clinical nutrition market is projected to reach USD 13 billion by 2027 owing to the deep internet penetration and surging preference for ordering through online channels and e-commerce portals. Online channels offer wide variety of medical nutrition products, driving the consumer preference towards using digital platforms that offer high convenience, healthy discounts and quick delivery among other services.

Moreover, COVID-19 pandemic and travelling restrictions in place is estimated to impel the growth of online channel substantially. Restriction resulted in high dependence on online channel for providing clinical nutrition products. Several firms ventured and initiated digital platforms for online distribution of their products.

High demand for clinical nutrition products in the North America region to promote the regional growth

Global Clinical Nutrition Market

Get more details on this report - Request Free Sample PDF


U.S. dominated the North America clinical nutrition market and was valued at over USD 11.2 billion in 2020 driven by the unhealthy eating habits and high consumption of junk food leading to malnourishment. High fast food consumption leads to chronic health ailments as this food contains high amounts of trans fats, saturated fats and sodium. These components are known to increase the risk of hypertension, type 2 diabetes and cardiovascular diseases. In the U.S., the calories consumed by the children outside home is higher and account for 55%, pointing towards heavy junk food consumption. As per the research studies, high junk food consumption leads to increased risk of metabolic disorders, overweight and obesity.

Germany held majority share in Europe clinical nutrition market and will cross USD 3.8 billion by 2027 propelled by the high number of people suffering from chronic diseases, growing geriatric population and rising prevalence of metabolic disorders in the country. As per a published article, numerous epidemiological studies have highlighted growing prevalence of chronic ailments such as cardiovascular diseases, hypertension, myocardial infarction and cerebrovascular disease among others. The high prevalence of metabolic syndrome that is characterized by abnormalities such as hypertension, abdominal obesity, dyslipidaemia and elevated blood glucose levels is also reported high in the country. The number of multimorbid patients in Germany are also rising with growing age. A survey conducted by the Germany Health Update reported overall prevalence of multimorbid patients over 39% amongst the participants.

Strategies adopted by major market players surging the industry growth

Some of the major companies operating in the market are Nestle Health Science, Fresenius Kabi, Abbott Laboratories, Danone, B Braun Melsungen AG, Baxter International Inc., Mead Johnson (Reckitt Benckiser), and Perrigo. These prominent participants emphasize on strategic initiatives such as collaborations, partnerships, new product launch & commercialization for business development. Furthermore, these leaders are heavily investing in research that enables them to launch innovative products in the market and garner maximum revenue.

Recent industry developments:

  • In August 2020, Nestle Health Science (part of Nestle SA) entered into a definitive agreement for acquisition of IM HealthScience. IM HealthScience offers products in medical nutrition that meet specific nutritional requirements for several diseases. This strategic acquisition assisted the company to strengthen and expand its dietary management product portfolio.
  • In July 2020, Danone announced EUR 100 million investment for its specialized nutrition product expansion in China. This investment assisted the company to broaden its nutritional product offerings tailored to Chinese health needs and reinstate its market position in the country.

Clinical nutrition market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product, 2016 - 2027 (USD Million)

  • Infant Nutrition
    • Milk based
    • Soy based
    • Organic formulas
    • Others
  • Enteral Nutrition
    • Standard Composition
    • Disease Specific Composition
  • Parenteral Nutrition
    • Amino Acids
    • Fats
    • Carbohydrates
    • Others

Market, By Consumer, 2016 - 2027 (USD Million)

  • Pediatric
  • Adult

Market, By Application, 2016 - 2027 (USD Million)

  • Cancer
  • Metabolic Disorders
  • Neurological Diseases        
  • Gastrointestinal Disorders   
  • Others

Market, By Distribution channel, 2016 - 2027 (USD Million)

  • Retail Stores
  • Pharmacies & Drug Stores
  • Online Channels
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Clinical nutrition market size had reached at over USD 45.8 billion in 2020 and will record a CAGR of over 8% through 2027 with rising incidences of chronic and metabolic disorders.

Infant nutrition market had captured over 54.7% share in 2020 owing to increasing preterm births coupled with several campaigns to promote the use of medical nutrition products for new-born.

Pediatric segment had held 58.7% market share in 2020 due to rising prevalence of malnutrition and related conditions across the world.

Cancer segment was valued at USD 7.1 billion in 2020 on account of increasing incidences of cancer and growing awareness regarding significance of clinical nutrition in cancer treatment.

North America clinical nutrition market had recorded a valuation of over USD 11.2 billion in 2020 on account of unhealthy eating habits and high consumption of junk food leading to malnourishment.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Published Date: Jul 2021
  • Companies covered: 10
  • Tables & Figures: 411
  • Countries covered: 18
  • Pages: 200

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount